The Global Biodegradable
Stents Market, by Product Type (Coronary Stents and Peripheral Stents), by
Material Type (Polymer-based Stents and Metallic Stents), by End User
(Hospitals, Specialty Clinics, and Ambulatory Surgical Centers) and by Region
(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
is estimated to be valued at US$ 278.6 million in 2018, and is projected to
exhibit a CAGR of 15.6% over the forecast period (2018 – 2026).
Biodegradable stents are fully degradable mesh
like network used for the treatment of blockage in arteries or guts or biliary
ducts. According to Transcatheter Cardiovascular Therapeutics (TCT) and
American College of Cardiology (ACC) the adoption of stents is expected to
shift from conventional metallic stents to bioresorbable stents, boosting the
biodegradable stents market growth. Biodegradable stents market is expected to
gain trajectory growth, owing to increasing number of approved products in
market. For instance in 2016, Abbott Laboratories received approval for Absorb
bioresorbable heart stent in Japan indicated for treatment of coronary artery
disease.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1917
In same year, Biotronik received
CE approval for Magmaris, a bioresorbable scaffold. The product offers easier
delivery and more strength resisting inward forces once deployed. In 2015,
Boston Scientific received FDA approval for Synergy, first bioresorbable stent
to unblock clogged arteries via drug elution. In June 2018, REVA medical, Inc.,
received CE approval for Fantom Encore Product line, which comprises of third
generation coronary bioresorbable scaffold. Furthermore, company is also
planning to expand its presence in Europe, Middle East, and South America via
distribution partnership. In same month, AMG International received CE approval
for Archimedes, a biodegradable stent for treatment of obstructive biliary and
pancreatic disorders. Such recent product approval are expected to boost the
market growth in near future.
Browse Market Data 32 Tables and
30 Figures spread through 150 Pages and in-depth TOC on " Biodegradable Stents
Market, by Product Type (Coronary Stents and Peripheral Stents), by Material
Type (Polymer-based Stents and Metallic Stents), by End User (Hospitals,
Specialty Clinics and Ambulatory Surgical Centers) and by Region - Global
Forecast to 2026”
As of 2017, Abbott was the only
company which has approval for completely bioresorbable stents. This offers
wide opportunity for the market players as well as new entrant to come up with
new fully degradable biodegradable stents to surpass the market. For instance,
according to article published in Springer Healthcare, 2013, REVA and ABSORB
are the ongoing clinical trials of completely biodegradable stents.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/biodegradable-stents-market-1917
Key Takeaways of the
Biodegradable Stents Market:
The global biodegradable stents
market is expected to expand at a CAGR of XX% during the forecast period (2018
– 2026), owing to increasing product launches
Coronary stents segment is
expected to dominate product type, owing to increasing cases of arteries
blockage
Polymer-based stents hold
dominant position in material segment due to more number of product under
polymer-based segment and its rising preference amongst medical professionals
Some of the major players
operating in global biodegradable stents market include Boston Scientific
Corporation, Abbott, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical
Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc.,
and Arterial Remodeling Technologies SA
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1917
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment